Skip to main content
. Author manuscript; available in PMC: 2022 May 6.
Published in final edited form as: Plast Reconstr Surg. 2017 Aug;140(2):240–251. doi: 10.1097/PRS.0000000000003508

Table 3.

Average Length of Stay

No. LOS (days) p *
Group
 Controls 40 4.05 ± 1.26
 TAP-Cath 48 3.52 ± 0.92
 TAP-LB 40 2.65 ± 0.66
Global <0.0001
 TAP-Cath vs. controls 0.0234
 TAP-LB vs. controls <0.0001
 TAP-LB vs. TAP-Cath <0.0001

LOS, length of stay; TAP-Cath, transversus abdominis plane–catheter; TAP-LB, transversus abdominis plane–liposomal bupivacaine.

*

Models were adjusted for timing of surgery.

Determined using the Welch analysis of variance.

Pairwise comparisons were performed using the Welch t test with the Bonferroni correction value of p = 0.016.